Trials / Completed
CompletedNCT04461002
Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.
Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of WHO II and III Grade Incident Gliomas.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 22 (actual)
- Sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
From the medical records of a series of patients operated on for incident grade II and III glioma, the primary objective is to evaluate the correlation between the molecular profile of tumours and preoperative imaging data (by FDG and FDOPA PET-scan and multimodal MRI).
Detailed description
A retrospective monocentre study of medical data (clinical, histological, molecular and imaging) contained in the medical records of patients operated on for Grade II or III incident glioma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Retrospective analysis | Evaluate the correlation between tumour molecular profile and preoperative imaging data (FDG and FDOPA PET-scan and multimodal MRI). |
Timeline
- Start date
- 2019-09-30
- Primary completion
- 2024-06-30
- Completion
- 2024-06-30
- First posted
- 2020-07-08
- Last updated
- 2024-07-03
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04461002. Inclusion in this directory is not an endorsement.